TB DR Mohabbat
TB DR Mohabbat
TB DR Mohabbat
Muhabbat Ali
Roll no 14
Definitio
n
T.B is a specific
communicable disease
caused by MYCOBACTERIUM
TUBERCULOSIS. (and other
variants of MYCOBACTERIUM).
Historical Context
HIPPOCRATES (460 B.C), the father of medicine called it phthisis,
which means to dry up.
The disease was also referred to as Captain of men of death
and The Great White Plague.
IN 1882 ROBERT KOCK, discovered the causative agent. In 1895
Roentgen discovered X-rays.
In 1907, Pirquet discovered the TUBERCULIN TEST.
Soon after the First World War, the BCG vaccination evolved by
French scientist, CALMETTE and GUERIN was tested in 1972 and
its success led to large implementation of prevention.
Remarkable progress in T.B control was with the discovery of
Streptomycin (1944), PAS (1946) and Isoniazed (1951).
Introducti
on
Tuberculosis (TB) is a contagious disease.
Like the common cold, it spreads through
the air. Only people who are sick with TB in
their lungs are infectious. When infectious
people cough, sneeze, talk or spit, they
propel TB germs, known as bacilli, into the
air. A person needs only to inhale a small
number of these to be infected.
Left untreated, each person with active TB
disease will infect on average between 10
and 15 people every year.
Introduction cont..
Someone in the world is newly infected
with TB bacilli every second.
Overall, one-third of the world's
population is currently infected with the
TB bacillus.
5-10% of people who are infected with
TB bacilli (but who are not infected with
HIV) become sick or infectious at some
time during their life. People with HIV
and TB infection are much more likely
to develop TB
Prevalence and mortality rates appear to be falling in
all six WHO regions.
Thus, the Americas, the eastern Mediterranean, and
Southeast Asia appear likely to meet the Millennium
Development Goals target, set in conjunction with the
Stop TB Partnership and the World Health Assembly,
of halving tuberculosis prevalence and tuberculosis-
related mortality between 1990 and 2015.
This target will probably not be met by the African
and European regions.
Some 22 high-burden countries collectively account
for 80% of the global tuberculosis burden.
incidence
According to the 13th annual tuberculosis report of
the World Health Organization (WHO) — published on
World TB Day, March 24, 2009 — there were an
estimated 9.27 million new cases of tuberculosis
worldwide in 2007.
Although this figure represents an increase from
9.24 million in 2006, the world population has also
grown, making the number of cases per capita a
more useful measure of the problem; this figure
peaked in 2004 at 142 per 100,000 and fell to 139
per 100,000 in 2007.
Situation in PAKISTAN
Pakistan ranks 6th among the countries of
the Eastern Mediterranean Region (EMRO) of
World Health Organization (WHO), in terms of
TB disease burden.
Every year about 250,000 new cases are
included in the country's TB burden.
Despite the fact that the government, with
huge support from international health
agencies, considered TB an emergency in
2001, given TB a priority and implemented
DOTS all over the country; the case detection
rate is still low (27% in 2004).
Determinants of
Tuberculosis
In spite of available modern technology
for prevention and control of tuberculosis,
the disease poses a major public health
problem in Pakistan.
Followings are key determinants
regarding this problem.
Etiological agent
Mycobacterium tuberculosis, an acid fast
gram positive, non-motile, aerobic rod
shaped organism, which grows with
difficulty in special medium.
Source of infection
sputum or excreta of T.B patient
containing Tubercle bacilli.
Objectives:
To enhance the TB case detection through
Public Private Mix (PPM) model by involving
private practitioners in collaboration with
National TB Control Program, (NTP) in district
Rajanpur in 12 months period.
To provide timely diagnosis of at least
sputum-smear positive (infectious) TB patients
(those most at risk of death and transmitting
disease).
To enhance awareness and information
regarding prevention and control of T.B
Steps in Implementation the
Intervention
The scale of the project will be of a pilot nature
and the expected outcomes of the Intervention
will show how the private physicians behaved in
collaborating with the government and how do
they practice the standard guidelines for the
management of tuberculosis.
Only those Private physicians, who are treating TB
patients at their private practice, will be given
invitations to attend training workshop on the
Tuberculosis-Directly Observed Treatment Short
course (DOTS) based on the guidelines of World
Health Organization.
. Their knowledge of the TB-DOTS prior to and after the
training was assessed through a questionnaire which
addressed the key issues in the management of TB.
At the end of the training a written consent of voluntary
participation in the Project will be taken from all the
participants and an introduction about the project will be
provided. The PPs will also be informed that they should
refer suspected TB cases for sputum microscopy and
register the patients with the NTP.
. The PPs will be given an incentive for every TB
diagnosed sputum smear positive patient.
A field coordinator will monitor and facilitate
the whole process. The PPs will also visit
regularly by the Project team as well as by the
district NTP coordinator.
TB patients' data will be collected from all
participating PPs during the study period of 12
months regarding number of suspected TB
cases, new sputum smear positive cases, and
patients' demographic and socioeconomic
data.
On the other side for the comparison, NTP
data of the study area regarding number of
new sputum smear positive TB cases will be
collected from NTP office.
Monitoring
The project coordinator of the field will take
the TB1 forms from the physicians where
patients will be registered with the district
TB Coordinator office of Rajanpur.